No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Specialties
CUREXO, Inc. specializes in the creation and distribution of medical technology. The company's activities are organized across three primary divisions: Medical Robot, Implant, and Trade. Its Medical Robot segment focuses on advanced robotic systems designed for surgical procedures, such as joint replacement and spinal operations, in addition to rehabilitation robots and other specialized medical devices. The Implant division is dedicated to manufacturing artificial joint prostheses and a range of other internal body implants. A unique aspect of the company is its Trade division, which manages the import and sale of food products. CUREXO was established on February 29, 1992, and its main offices are situated in Seoul, South Korea.
www.curexo.comNo one on the platform currently holds 060280.KQ.
No tracked institution reports a position in 060280.KQ as of their last filing.
No one on the platform has traded 060280.KQ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.9% | — | — | — | ||
| Rev. Growth % | 34.2% | 13.7% | ||||
| Profit Margin % | 3.7% | -5.8% | -16.0% | |||
| Free Cash Flow Margin % | -18.4% | -11.4% | -27.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $80.7B | +8.0% | $171.00 | $171.00–$171.00 | — | 1 |
| 2027 | $96.0B | +19.0% | $204.00 | $204.00–$204.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 060280.KQCurexo Inc. | $7970.00 | +0.63% | $328.8B | — |
| 041830.KQInBody Co.,Ltd | $58300.00 | +2.82% | $777.8B | — |
| 041960.KQKomipharm International Co., Ltd. | $9820.00 | +6.05% | $705.9B | — |
| 043150.KQValue Added Technology Co., Ltd. | $17560.00 | -1.35% | $260.8B | — |
| 047920.KQHLB Pharmaceutical Co., Ltd | $6700.00 | +3.88% | $219.8B | — |
| 078160.KQMEDIPOST Co., Ltd. | $8700.00 | +0.00% | $340.0B | — |
| 099190.KQi-SENS, Inc. | $16260.00 | +0.00% | $465.8B | — |
Source: Financial Modeling Prep · peers by sector/industry